Current Pharmacological Therapies in Heart Failure Patients
Explore this paper's citation graph
Summary
Current treatment approaches target both hemodynamic alterations and the neurohumoral elements to slow disease progression as well as to improve symptoms and outcomes.
- Type
- article
- Published
- 2017-03-27
- Cited by
- 21
- References
- 53
- OpenAlex
- https://openalex.org/W28349441
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:12539058
Keywords
Uranium dioxide, Precipitation, Uranium, Ammonium, Radiochemistry
References
- Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)
- The global health and economic burden of hospitalizations for heart failure: lessons learned from hospitalized heart failure registries.
- Burden of new hospitalization for heart failure: a population‐based investigation from Italy
- Beta-blockade with nebivolol in elderly heart failure patients with impaired and preserved left ventricular ejection fraction: Data From SENIORS (Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors With Heart Failure).
- Effects on outcomes of heart rate reduction by ivabradine in patients with congestive heart failure: is there an influence of beta-blocker dose?: findings from the SHIFT (Systolic Heart failure treatment with the I(f) inhibitor ivabradine Trial) study.
- Efficacy and safety of LCZ696 (sacubitril-valsartan) according to age: insights from PARADIGM-HF
- Epidemiology and risk profile of heart failure
- Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).
- Effects of Digoxin on Morbidity and Mortality in Diastolic Heart Failure: The Ancillary Digitalis Investigation Group Trial
- Effect of nebivolol on outcome in elderly patients with heart failure and atrial fibrillation: insights from SENIORS
- A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure.
- Evidence-based therapy for heart failure.
- Effect of the angiotensin-receptor-neprilysin inhibitor LCZ696 compared with enalapril on mode of death in heart failure patients.
- Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial.
- Angiotensin-neprilysin inhibition versus enalapril in heart failure.
- Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial.
- Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial.
- Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study.
- The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial.
- Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.
Cited by
- Management protocols for chronic heart failure in India
- Hydrogen Sulfide Attenuates Renin Angiotensin and Aldosterone Pathological Signaling to Preserve Kidney Function and Improve Exercise Tolerance in Heart Failure
- Biphenyl Acid Derivatives as APJ Receptor Agonists.
- Comments About: Prognostic Significance of Heart Rate and Beta-Blocker Use in Sinus Rhythm in Patients with Heart Failure and Preserved Ejection Fraction
- Can Heat Therapy Help Patients with Heart Failure?
- Qishen granules exerts cardioprotective effects on rats with heart failure via regulating fatty acid and glucose metabolism
- Protocatechualdehyde protects oxygen-glucose deprivation/reoxygenation-induced myocardial injury via inhibiting PERK/ATF6α/IRE1α pathway.
- Impact of Sacubitril–Valsartan Treatment on Diastolic Function in Patients with Heart Failure and Reduced Ejection Fraction
- Assessment of human bioengineered cardiac tissue function in hypoxic and re-oxygenized environments to understand functional recovery in heart failure
- New Targets in Heart Failure Drug Therapy
- Vascular and metabolic effects of SGLT2i and GLP-1 in heart failure patients
- Sacubitril/Valsartan as a Therapeutic Tool Across the Range of Heart Failure Phenotypes and Ejection Fraction Spectrum
- Improvement of Heart Function After Transplantation of Encapsulated Stem Cells Induced with miR-1/Myocd in Myocardial Infarction Model of Rat
- Differentiation of Mesenchymal Stem Cells Into Cardiac-like Cells by Co-induction of Lentiviruses Containing Mir-1 and Myocd in Chitosan Collagen Hydrogel Scaffold
- Cheyne-Stokes Respiration Perception via Machine Learning Algorithms
- Characteristics and management of very elderly patients with heart failure: a retrospective, population cohort study
- Evaluation of Potential Biomarkers for Traditional Chinese Medicine-Based Chronic Heart Failure Syndromes; a case-control study
- Feasibility and Acceptability of Wearable Cameras to Assess Self-care in People With Heart Failure: Pilot Study
- The emerging role of sacubitril/valsartan in pulmonary hypertension with heart failure
- Ginsenoside Rb2 improves heart failure by down-regulating miR-216a-5p to promote autophagy and inhibit apoptosis and oxidative stress.